Products

What will AGI do for Adalimumab?

This classification denotes a monoclonal antibody and biological response modifier with the molecular formula C6428H9912N1694O1987S46, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) FYS6T7F842, more generally known as adalimumab. European Medicines Agency schedules adalimumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20016. The term ADALIMUMAB is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). As of Q4 2014, ADALIMUMAB remains US FDA's Preferred Term for this commodity. Adalimumab bears US NLM identifiers UMLS ID C1122087 and NCI Concept Code C65216. Most nations, for tariff and trade purposes, schedule adalimumab under HS 30021091 and SITC 54163. For the most current information on WCO designations on adalimumab and salts thereof, please see Committee proceedings HSC/27, NC0430B2 Ann. Q/1 (I) (2001). SMILES: none.